Dr. Linden Hu is the Paul and Elaine Chervinsky Professor of Immunology at Tufts University School of Medicine. Dr. Hu received his A.B. and M.D. from Brown University. He completed training in Infectious Diseases at Tufts Medical Center. His laboratory works on multiple aspects of Lyme disease including vaccine development, new diagnostics and treatments, and understanding interactions between Borrelia burgdorferi and its tick and animal hosts. Most recently, his lab has been researching how the organism evades the host immune response and how human genetic mutations may alter the ability of the bacterial host to control inflammatory responses. The lab is also partnering with other laboratories on strategies to eradicate tick borne pathogens from their wild reservoirs.
Tufts University researchers have received a $20.7 million grant to lead the largest NIH-funded prospective study of patients with chronic Lyme disease to date, following patients from their earliest diagnosis to better identify why some people go on to develop debilitating symptoms later on.
17-Sep-2024 10:05:40 AM EDT
Tufts experts explain more about babesiosis, which is on the rise in the U.S.
31-Oct-2023 12:05:59 PM EDT
Scientists at Tufts University School of Medicine have developed a genome-scale metabolic model or “subway map” of key metabolic activities of the bacterium that causes Lyme disease.
16-Oct-2023 06:05:43 AM EDT
Researchers in Tufts University’s Lyme Disease Initiative recently received grants totaling more than $7 million to build on an already impressive array of discoveries that Tufts’ teams have made to combat tick-borne diseases.
19-Sep-2023 11:05:51 AM EDT
Warm weather means tick season. Faculty at the School of Medicine and Cummings School of Veterinary Medicine share tips for staying healthy outdoors.
04-May-2023 09:40:26 AM EDT
Researchers at Tufts University School of Medicine have identified a key testing area for Lyme disease that could potentially help clinicians diagnose the disease sooner, know whether treatment with antibiotics is working, and identify patients who have been reinfected.
11-Mar-2022 03:30:12 PM EST